Chromosomal microarray testing yield in 829 cases of microcephaly: a clinical characteristics-based analysis for prenatal and postnatal cases
Archives of Gynecology and Obstetrics · 2024
DOI: 10.1007/s00404-024-07388-3 ↗Kurz gefasst
Fachartikel in der Zeitschrift Archives of Gynecology and Obstetrics, 2024. Verfasst von Rivka Sukenik-Halevy und 8 weiteren Autor:innen. Beteiligte Einrichtung: Genetic Institute, Meir Medical Center, Kfar Saba, Israel. Riki.sukenik@gmail.com. Hauptthemen laut MEDLINE: Microcephaly, Microarray Analysis. Die Arbeit nennt 28 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Tel Aviv University.
Abstract (Originalsprache)
Introduction
Microcephaly, characterized by abnormal head growth, can often serve as an initial indicator of congenital, genetic, or acquired disorders. In this study, we sought to evaluate the effectiveness of chromosomal microarray (CMA) testing in detecting abnormalities in both prenatal and postnatal cases of microcephaly. Materials and methods CMA Testing: We conducted CMA testing on 87 prenatally-detected microcephaly cases and 742 postnatal cases at a single laboratory. We evaluated the CMA yield in relation to specific clinical characteristics.
Results
In prenatal cases, pathogenic and likely pathogenic (LP) results were identified in 4.6% of cases, a significantly higher rate compared to low-risk pregnancies. The male-to-female ratio in this cohort was 3, and the CMA yield was not influenced by gender or other clinical parameters. For postnatal cases, the CMA yield was 15.0%, with a significantly higher detection rate associated with dysmorphism, hypotonia, epilepsy, congenital heart malformations (CHM), learning disabilities (LD), and a history of Fetal growth restriction (FGR). No specific recurrent copy number variations (CNVs) were observed, and the rate of variants of unknown significance was 3.9%.
Conclusions
The yield of CMA testing in prenatal microcephaly is lower than in postnatal cases (4.6% vs. 15%). The presence of microcephaly, combined with dysmorphism, hypotonia, epilepsy, CHD, LD, and FGR, significantly increases the likelihood of an abnormal CMA result.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Genetic Institute, Meir Medical Center, Kfar Saba, Israel. Riki.sukenik@gmail.com.
- School of Medicine, Faculty of Medical and Health Sciences, Tel Aviv University, Tel Aviv, Israel. Riki.sukenik@gmail.com.
- Genetic Institute, Meir Medical Center, Kfar Saba, Israel.
- School of Medicine, Faculty of Medical and Health Sciences, Tel Aviv University, Tel Aviv, Israel.
- Recanati Genetic Institute, Rabin Medical Center, Petah Tikva, Israel.
- Felsenstein Medical Research Center, Rabin Medical Center, Petah Tikva, Israel.
Förderung
- Tel Aviv University
Zitieren
APA
Sukenik-Halevy, R., Mevorach, N., Basel-Salmon, L., Matar, R. T., Kahana, S., Klein, K., Agmon-Fishman, I., Levy, M., & Maya, I. (2024). Chromosomal microarray testing yield in 829 cases of microcephaly: a clinical characteristics-based analysis for prenatal and postnatal cases. Archives of Gynecology and Obstetrics. https://doi.org/10.1007/s00404-024-07388-3
Vancouver
Sukenik-Halevy R, Mevorach N, Basel-Salmon L, Matar RT, Kahana S, Klein K, et al. Chromosomal microarray testing yield in 829 cases of microcephaly: a clinical characteristics-based analysis for prenatal and postnatal cases. Archives of Gynecology and Obstetrics. 2024. doi:10.1007/s00404-024-07388-3
BibTeX
@article{SukenikHalevy2024,
author = {Sukenik-Halevy, Rivka and Mevorach, Nir and Basel-Salmon, Lina and Matar, Reut Tomashov and Kahana, Sarit and Klein, Kochav and Agmon-Fishman, Ifaat and Levy, Michal and Maya, Idit},
title = {Chromosomal microarray testing yield in 829 cases of microcephaly: a clinical characteristics-based analysis for prenatal and postnatal cases},
journal = {Archives of Gynecology and Obstetrics},
year = {2024},
doi = {10.1007/s00404-024-07388-3}
}
EUVIMED